ContextVision AB (publ) (OSL:CONTX)

Market Cap	340.36M
Revenue (ttm)	122.97M
Net Income (ttm)	9.98M
Shares Out	75.81M
EPS (ttm)	0.13
PE Ratio	34.50
Forward PE	60.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,134
Average Volume	46,287
Open	4.480
Previous Close	4.490
Day's Range	4.480 - 4.490
52-Week Range	4.000 - 6.600
Beta	0.67
RSI	45.81
Earnings Date	Nov 6, 2025

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1989
• Employees: 40
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2024, ContextVision AB's revenue was 130.84 million, a decrease of -1.33% compared to the previous year's 132.60 million. Earnings were 24.68 million, a decrease of -24.60%.

Financial numbers in SEK